Studsvik is creating a new customer-oriented organization. The change aims to increase the Group’s commercial focus, understanding of customer needs, enable synergies, clarify responsibilities and enable profitable growth in selected service and product offerings. The new organization, which will enter into force on January 1, 2014, will be divided into three Business Areas; Waste Treatment; focusing on the management and treatment of radioactive waste. The Business Area's main markets are in Europe and the USA with plants in Sweden, the UK and the USA. Mats Fridolfsson, currently Head of Segment USA and former Head of Segment Sweden, has been appointed President, Business Area Waste Treatment. Consultancy Services; providing qualified consulting services in areas such as radiological protection, waste, engineering and decommissioning at nuclear facilities and oil and gas installations. The Business Area serves a global market. Stefan Berbner, currently Head of Segment Germany, has been appointed President, Business Area Consultancy Services. Operating Efficiency; focusing on issues of fuel and reactor operation. The market is global and Studsvik offers both world leading software for optimization and monitoring of fuel and testing and evaluation of materials in own laboratories in Sweden. Michael Mononen, Chief Executive Officer of Studsvik AB, will be acting President, Business Area Operating Efficiency. Furthermore, Sam Usher, who is currently Head of Segment UK, has been appointed Senior Vice President, Business Development. As a result of the new organization, as of January 1, 2014 Studsvik Group Management will consist of; · Michael Mononen, Chief Executive Officer and acting President of Operating Efficiency · Pål Jarness, CFO · Mats Fridolfsson, President of Waste Treatment · Stefan Berbner, President of Consultancy Services · Sam Usher, Senior Vice President, Business Development "I see the changes as important steps in our efforts to create clarity in terms of customer focus, accountability and efficient processes. By making these changes we lay the foundation for profitability and future growth. We want to get closer to our customers, focusing on products and services with a high knowledge content and where Studsvik has or can take a leading position in the market, by creating and delivering additional value to our customers," said Michael Mononen, Chief Executive Officer of Studsvik AB. A conference call for media and analysts will be held today at 11:30 am CET. For call in details, please see separate press release distributed in parallel with this press release. For further information, please contact: Michael Mononen, Chief Executive Officer, +46 155 22 10 86 Jerry Ericsson, CFO (until December 31, 2013), +46 155 22 10 32 or +46 760 02 10 32. Facts about Studsvik Studsvik offers a range of advanced technical services to the international nuclear power industry in such areas as waste treatment, decommissioning, engineering & services, and operating efficiency. The company has more than 60 years experience of nuclear technology and radiological services. Studsvik is a leading supplier on a rapidly expanding market. Studsvik has 1,100 employees in 7 countries and the company’s shares are listed on the NASDAQ OMX Stockholm. Studsvik is publishing this information pursuant to the Securities Market Act and/or the Financial Instruments Trading Act. The Information was released for public disclosure on November 18, 2013 at 08:30 AM CET. www.studsvik.com
Reorganization at Studsvik for better customer focus and
Top 10 Most Recent News Articles
Faith and Resilience in China: The Legacy of the Long March
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Lundbeck's Board Leadership Transitions into New Era
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
UEG's New Advisory Board: Elevating Patient Voices
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue ReadingTop 5 Most Recently Viewed Articles
Thermo Fisher's Role as the Leading Partner in Biopharma
Thermo Fisher's Role in Revolutionizing Biopharma Thermo Fisher Scientific Inc. (TMO) is increasingly becoming the cornerstone of the biopharma sector. Although some analysts have observed a recent dip in its stock performance, there is a strong belief in its capability to rebound through strategic acquisitions and promising growth prospects. Notably, Thermo Fisher boasts...
Continue Reading
Jamf Unveils Comprehensive Reinvestment Strategy for Growth
Jamf's Strategic Reinvestment Initiative In a bold move aimed at enhancing operational efficiency and shareholder value, Jamf (NASDAQ: JAMF) has announced a strategic reinvestment plan designed to propel long-term growth. This initiative comes on the heels of a comprehensive systems update that has illuminated new business opportunities and operational insights. Enhancing...
Continue Reading
Fidelity D & D Bancorp, Inc. Sees Earnings Impact in Q3
Fidelity D & D Bancorp, Inc. Announcements on Financial Standing In recent news regarding Fidelity D & D Bancorp, Inc. (NASDAQ: FDBC), the company revealed its latest financial results, marking a significant quarter in their ongoing operations. As of September 30, 2024, Fidelity Bank, under the leadership of President and CEO Daniel J. Santaniello, has recorded key...
Continue Reading
Deutsche Bank Lowers Boeing Price Target, Retains Buy Rating
Deutsche Bank's Strategic Assessment of Boeing Recently, Deutsche Bank has made headlines with its updated financial outlook for Boeing (NYSE: BA), decreasing the stock price target from $225.00 to $195.00. However, they have maintained a Buy rating on the aerospace company's shares. This adjustment comes in response to expected larger free cash flow (FCF) burn for the...
Continue Reading
TIGRIS Aquatic Services Expands With LakePro Acquisition
TIGRIS Aquatic Services Expands With LakePro Acquisition TIGRIS Aquatic Services, LLC has made a significant move by acquiring LakePro, Inc., a prominent player in the field of aquatic management. This acquisition opens new opportunities for TIGRIS, expanding its operational reach into fresh markets and reinforcing its commitment to creating safe and well-managed water...
Continue Reading